Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaafar Bennouna

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Cancer Chemotherapy and Pharmacology|November 21, 2016
Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trialMichel Ducreux, Jaafar Bennouna, Antoine Adenis, et al.
Oncology|October 6, 2017
Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4)Marie Robert, Marta Jarlier, Sophie Gourgou, et al.
Idcases|July 8, 2022
A fatal case associated with <i>Catabacter hongkongensis</i> bacteremia in lung cancer patient: A case reportValentin Mandin, Stéphane Corvec, Anne-Laure Chéné, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
V gamma 9V delta 2 T cell response to colon carcinoma cellsMurielle Corvaisier, Agnès Moreau-Aubry, Elisabeth Diez, et al.
Bulletin Du Cancer|January 31, 2022
[Re-visiting the Pronopall score ten years later: A multicenter retrospective study]Lucie Duval, You-Heng Lam, Elvire Pons-Tostivint, et al.
Clinical Lung Cancer|April 24, 2016
Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the LungMony Ung, Isabelle Rouquette, Thomas Filleron, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2023
Impact of first-line immunotherapy on survival and intracranial outcomes in a cohort of non-small cell lung cancer patients with brain metastases at diagnosisBenoit Nigen, Thomas Goronflot, Guillaume Herbreteau, et al.
Lung Cancer (Amsterdam, Netherlands)|July 11, 2024
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter studyElvire Pons-Tostivint, Remy Ezzedine, Thomas Goronflot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung CancersChristos Chouaid, Laura Luciani, Katell LeLay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2011
Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patientsCaroline Tournoux-Facon, Hélène Senellart, Etienne Lemarie, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|November 21, 2016
Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trialMichel Ducreux, Jaafar Bennouna, Antoine Adenis, et al.
Oncology|October 6, 2017
Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4)Marie Robert, Marta Jarlier, Sophie Gourgou, et al.
Idcases|July 8, 2022
A fatal case associated with <i>Catabacter hongkongensis</i> bacteremia in lung cancer patient: A case reportValentin Mandin, Stéphane Corvec, Anne-Laure Chéné, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
V gamma 9V delta 2 T cell response to colon carcinoma cellsMurielle Corvaisier, Agnès Moreau-Aubry, Elisabeth Diez, et al.
Bulletin Du Cancer|January 31, 2022
[Re-visiting the Pronopall score ten years later: A multicenter retrospective study]Lucie Duval, You-Heng Lam, Elvire Pons-Tostivint, et al.
Clinical Lung Cancer|April 24, 2016
Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the LungMony Ung, Isabelle Rouquette, Thomas Filleron, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2023
Impact of first-line immunotherapy on survival and intracranial outcomes in a cohort of non-small cell lung cancer patients with brain metastases at diagnosisBenoit Nigen, Thomas Goronflot, Guillaume Herbreteau, et al.
Lung Cancer (Amsterdam, Netherlands)|July 11, 2024
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter studyElvire Pons-Tostivint, Remy Ezzedine, Thomas Goronflot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung CancersChristos Chouaid, Laura Luciani, Katell LeLay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2011
Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patientsCaroline Tournoux-Facon, Hélène Senellart, Etienne Lemarie, et al.
Pageof 17